THURSDAY, Might 7, 2020 (HealthDay News) — In the scramble to uncover medications that conquer back COVID-19, scientists from Italy report encouraging results from a smaller review on a rheumatoid arthritis drug already in use.
The drug, anakinra, may possibly assist peaceful the runaway immune reaction acknowledged as a “cytokine storm,” which imperils some individuals with intense COVID-19.
“Right until a vaccine is offered, we urgently require to uncover a way to assist folks survive the most intense symptoms of COVID-19, and to do that devoid of frustrating the intense care potential of hospitals,” spelled out review creator Dr. Lorenzo Dagna in a information release from The Lancet Rheumatology. His team posted the findings in the journal on Might 7.
“A procedure [like anakinra] that has already achieved stringent safety assessments and that is offered in sufficient quantities to meet the desires of the current pandemic is ideal,” explained